August 14, 2024
Trinity Biotech Announces Q2 2024 Financial Results
DUBLIN, Ireland (August 14, 2024)- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the Company’s results for the quarter ended June 30, 2024.